Cleared Traditional

K251061 - NAEOTOM Alpha.Peak/NAEOTOM Alpha

Also marketed or referenced as:
NAEOTOM Alpha.Pro NAEOTOM Alpha.Prime

K251061 is an FDA 510(k) clearance for NAEOTOM Alpha.Peak/NAEOTOM Alpha, manufactured by Siemens Medical Solutions USA, Inc.. The device is a Class 2 Radiology device with product code JAK cleared through the Traditional 510(k) pathway after a 115-day FDA review.

K251061 · Siemens Medical Solutions USA, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2025
Decision
115d
Days
Class 2
Risk

K251061 is an FDA 510(k) clearance for the NAEOTOM Alpha.Peak/NAEOTOM Alpha. Classified as System, X-ray, Tomography, Computed (product code JAK), Class II - Special Controls.

Submitted by Siemens Medical Solutions USA, Inc. (Knoxville, US). The FDA issued a Cleared decision on July 28, 2025 after a review of 115 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1750 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Siemens Medical Solutions USA, Inc. devices

FDA 510(k) Submission Details - K251061

510(k) Number K251061 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 04, 2025
Decision Date July 28, 2025
Days to Decision 115 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
8d slower than avg
Panel avg: 107d · This submission: 115d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

JAK Device Classification - Class 2, Special Controls

Product Code JAK System, X-ray, Tomography, Computed
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1750
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - JAK System, X-ray, Tomography, Computed

All 715
Devices cleared under the same product code (JAK) and FDA review panel - the closest regulatory comparables to K251061.
OmniTom Elite with PCD
K250928 · Neurologica Corporation · Sep 2025
CT:VQ
K251484 · 4Dmedical Limited · Aug 2025
Revolution Vibe
K250941 · Ge Medical Systems, LLC · Aug 2025
Marie
K250970 · Leo Cancer Care · Jul 2025
SOMATOM go.Now
K250822 · Siemens Medical Solutions USA, Inc. · Jul 2025
Philips iCT CT system
K250648 · Philips Medical Systems Nederland B.V. · Jun 2025